Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Seizure Generalized”

177 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 177 results

Large-scale testing (Phase 3)Ended earlyNCT00693017
What this trial is testing

Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised Epilepsy

Who this might be right for
Epilepsy
Eisai Limited 10
Not applicableStudy completedNCT02381977
What this trial is testing

Prevalence of Acute Critical Neurological Disease in Children: a Global Epidemiological Assessment

Who this might be right for
Cardiac ArrestStrokeTraumatic Brain Injury+4 more
University of Pittsburgh 922
Not applicableStudy completedNCT06960811
What this trial is testing

Epileptic Psychoses and Their Link With Ictal Emotions and Consciousness

Who this might be right for
Epilepsy With Partial Onset Seizures With or Without Secondary GeneralizationPsychosesEpilepsy, Generalized
Central Hospital, Nancy, France 117
Post-approval studies (Phase 4)Study completedNCT00266604
What this trial is testing

Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy

Who this might be right for
EpilepsySeizuresEpilepsies, Partial+2 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 409
Not applicableStudy completedNCT00001325
What this trial is testing

Metabolic Abnormalities in Children With Epilepsy

Who this might be right for
Generalized EpilepsyInfantile SpasmsMetabolic Disease+2 more
National Institute of Neurological Disorders and Stroke (NINDS) 80
Large-scale testing (Phase 3)WithdrawnNCT05128344
What this trial is testing

Evaluate Safety and Efficacy of AMZ002 Treatment, Compared With Vigabatrin in Participants With Infantile Spasms

Who this might be right for
Spasms, Infantile
Amzell
Early research (Phase 1)Study completedNCT02286986
What this trial is testing

Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy

Who this might be right for
Epilepsy
University of Utah 26
Not applicableStudy completedNCT04252846
What this trial is testing

Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy

Who this might be right for
Idiopathic Generalized EpilepsyPartial Onset SeizuresGeneralised Tonic-Clonic Seizures
Eisai Limited 191
Large-scale testing (Phase 3)Study completedNCT00150748
What this trial is testing

Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy

Who this might be right for
Generalized Epilepsy
UCB Pharma SA 217
Not applicableUnknownNCT04291235
What this trial is testing

The NEUROlogically-impaired Extubation Timing Trial (NEURO-ETT)

Who this might be right for
Acute Brain Injury
Sunnybrook Health Sciences Centre 332
Not applicableLooking for participantsNCT06657378
What this trial is testing

Evaluate the Safety of Fycompa Injection in Participants With Partial-Onset Seizures or Primary Generalized Tonic- Clonic Seizures

Who this might be right for
Partial-Onset SeizuresPrimary Generalized Tonic-clonic Seizures
Eisai Co., Ltd. 110
Large-scale testing (Phase 3)Study completedNCT03201900
What this trial is testing

Study for Verification of Efficacy and Safety for Perampanel Monotherapy in Untreated Participants With Partial Onset Seizures (Including Secondarily Generalized Seizures (FREEDOM Study)

Who this might be right for
Partial Onset Seizures
Eisai Co., Ltd. 91
Not applicableStudy completedNCT02736162
What this trial is testing

Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Patients With Epilepsy

Who this might be right for
EpilepsyPartial-Onset SeizuresPrimary Generalized Tonic-Clonic Seizures
Eisai Inc. 61
Not applicableEnded earlyNCT04537832
What this trial is testing

Natural History Study of Infants and Children With Developmental and Epileptic Encephalopathies

Who this might be right for
Dravet Syndrome
Encoded Therapeutics 58
Large-scale testing (Phase 3)Ended earlyNCT03299842
What this trial is testing

Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet Syndrome

Who this might be right for
Dravet Syndrome
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. 5
Testing effectiveness (Phase 2)Study completedNCT01607073
What this trial is testing

Verapamil as Therapy for Children and Young Adults With Dravet Syndrome

Who this might be right for
Dravet Syndrome
Gillette Children's Specialty Healthcare 2
Testing effectiveness (Phase 2)Study completedNCT00162981
What this trial is testing

Clobazam in Subjects With Lennox-Gastaut Syndrome

Who this might be right for
EpilepsyEpilepsy, GeneralizedSeizures
Lundbeck LLC 68
Not applicableStudy completedNCT01178437
What this trial is testing

Transcutaneous Non-invasive Stimulation of the Vagus Nerve for the Treatment of Difficult-to-treat Epilepsy

Who this might be right for
Epilepsy
cerbomed GmbH 7
Large-scale testing (Phase 3)Looking for participantsNCT06579573
What this trial is testing

ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.

Who this might be right for
Epilepsy, Generalized
Ono Pharmaceutical Co., Ltd. 15
Testing effectiveness (Phase 2)Ended earlyNCT03336242
What this trial is testing

Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures

Who this might be right for
Childhood Absence Epilepsy
Radius Pharmaceuticals, Inc. 20
Next Page